1-9 of 9
Bruce H.R. Wolffenbuttel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High Diabetes Distress Among Ethnic Minorities Is Not Explained by Metabolic, Cardiovascular, or Lifestyle Factors: Findings From the Dutch Diabetes Pearl Cohort

Free
Behiye Özcan, Femke Rutters, Frank J. Snoek, Mandy Roosendaal, Eric J. Sijbrands, Petra J.M. Elders, Frits Holleman, Hanno Pijl, Cees J. Tack, Evertine J. Abbink, Harold W. de Valk, Bruce H.R. Wolffenbuttel, Coen D.A. Stehouwer, Nicholas C. Schaper, Jacqueline M. Dekker, Miranda T. Schram
Journal: Diabetes Care
Diabetes Care 2018;41(9):1854–1861
https://doi.org/10.2337/dc17-2181
Published: 26 June 2018
View articletitled, High Diabetes Distress Among Ethnic Minorities Is Not Explained by Metabolic, Cardiovascular, or Lifestyle Factors: Findings From the Dutch Diabetes Pearl Cohort
Open the PDF for High Diabetes Distress Among Ethnic Minorities Is Not Explained by Metabolic, Cardiovascular, or Lifestyle Factors: Findings From the Dutch Diabetes Pearl Cohort in another window
Includes: Supplementary data
Journal Articles

Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes

Open Access
Michaela Diamant, Michael A. Nauck, Rimma Shaginian, James K. Malone, Simon Cleall, Matthew Reaney, Danielle de Vries, Byron J. Hoogwerf, Leigh MacConell, Bruce H.R. Wolffenbuttel, for the 4B Study Group
Journal: Diabetes Care
Diabetes Care 2014;37(10):2763–2773
https://doi.org/10.2337/dc14-0876
Published: 10 September 2014
View articletitled, Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes
Open the PDF for Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Islet-After-Lung Transplantation in a Patient With Cystic Fibrosis–Related Diabetes

Open Access
H. Siebe Spijker, Bruce H.R. Wolffenbuttel, Wim van der Bij, Marten A. Engelse, Ton J. Rabelink, Eelco J.P. de Koning
Journal: Diabetes Care
Diabetes Care 2014;37(7):e159–e160
https://doi.org/10.2337/dc14-0639
Published: 12 June 2014
View articletitled, Islet-After-Lung Transplantation in a Patient With Cystic Fibrosis–Related Diabetes
Open the PDF for Islet-After-Lung Transplantation in a Patient With Cystic Fibrosis–Related Diabetes in another window
Journal Articles

Ethnic Differences in Glycemic Markers in Patients With Type 2 Diabetes

Open Access
Bruce H.R. Wolffenbuttel, MD, William H. Herman, MD, Jorge L. Gross, MD, Mala Dharmalingam, MD, Honghua H. Jiang, PHD, Dana S. Hardin, MD
Journal: Diabetes Care
Diabetes Care 2013;36(10):2931–2936
https://doi.org/10.2337/dc12-2711
Published: 14 September 2013
View articletitled, Ethnic Differences in Glycemic Markers in Patients With Type 2 Diabetes
Open the PDF for Ethnic Differences in Glycemic Markers in Patients With Type 2 Diabetes in another window
Journal Articles

The DURAbility of Basal versus Lispro mix 75/25 insulin Efficacy (DURABLE) Trial: Comparing the durability of lispro mix 75/25 and glargine

Open Access
John B. Buse, MD, Bruce H.R. Wolffenbuttel, MD, William H. Herman, MD, Stephen Hippler, MD, Sherry A. Martin, MD, Honghua H. Jiang, PHD, Sylvia K. Shenouda, PHD, Jessie L. Fahrbach, MD
Journal: Diabetes Care
Diabetes Care 2011;34(2):249–255
https://doi.org/10.2337/dc10-1701
Published: 20 January 2011
View articletitled, The DURAbility of Basal versus Lispro mix 75/25 insulin Efficacy (DURABLE) Trial: Comparing the durability of lispro mix 75/25 and glargine
Open the PDF for The DURAbility of Basal versus Lispro mix 75/25 insulin Efficacy (DURABLE) Trial: Comparing the durability of lispro mix 75/25 and glargine in another window
Includes: Supplementary data
Journal Articles

DURAbility of Basal Versus Lispro Mix 75/25 Insulin Efficacy (DURABLE) Trial 24-Week Results: Safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes

Open Access
John B. Buse, MD, PHD, Bruce H.R. Wolffenbuttel, MD, PHD, William H. Herman, MD, MPH, Natalie K. Shemonsky, MD, Honghua H. Jiang, PHD, Jessie L. Fahrbach, MD, Jamie L. Scism-Bacon, PHD, Sherry A. Martin, MD
Journal: Diabetes Care
Diabetes Care 2009;32(6):1007–1013
https://doi.org/10.2337/dc08-2117
Published: 31 March 2009
View articletitled, DURAbility of Basal Versus Lispro Mix 75/25 Insulin Efficacy (DURABLE) Trial 24-Week Results: Safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes
Open the PDF for DURAbility of Basal Versus Lispro Mix 75/25 Insulin Efficacy (DURABLE) Trial 24-Week Results: Safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes in another window
Includes: Supplementary data
Journal Articles

Influence of Elevated Cardiometabolic Risk Factor Levels on Treatment Changes in Type 2 Diabetes

Free
Jaco Voorham, MSC, Flora M. Haaijer-Ruskamp, PHD, Ronald P. Stolk, MD, PHD, Bruce H.R. Wolffenbuttel, MD, PHD, Petra Denig, PHD, the Groningen Initiative to Analyze Type 2 Diabetes Treatment (GIANTT) Group
Journal: Diabetes Care
Diabetes Care 2008;31(3):501–503
https://doi.org/10.2337/dc07-1043
Published: 01 March 2008
View articletitled, Influence of Elevated Cardiometabolic Risk Factor Levels on Treatment Changes in Type 2 Diabetes
Open the PDF for Influence of Elevated Cardiometabolic Risk Factor Levels on Treatment Changes in Type 2 Diabetes in another window
Journal Articles

Physician, Organizational, and Patient Factors Associated With Suboptimal Blood Pressure Management in Type 2 Diabetic Patients in Primary Care

Free
Carel F. Schaars, MD, Petra Denig, PHD, Willeke N. Kasje, MSC, Roy E. Stewart, MSC, Bruce H.R. Wolffenbuttel, MD, PHD, Flora M. Haaijer-Ruskamp, PHD
Journal: Diabetes Care
Diabetes Care 2004;27(1):123–128
https://doi.org/10.2337/diacare.27.1.123
Published: 01 January 2004
View articletitled, Physician, Organizational, and Patient Factors Associated With Suboptimal Blood Pressure Management in Type 2 Diabetic Patients in Primary Care
Open the PDF for Physician, Organizational, and Patient Factors Associated With Suboptimal Blood Pressure Management in Type 2 Diabetic Patients in Primary Care in another window
Journal Articles

Health-Related Quality of Life and Treatment Satisfaction in Dutch Patients With Type 2 Diabetes

Free
W. Ken Redekop, PHD, Marc A. Koopmanschap, PHD, Ronald P. Stolk, MD, PHD, Guy E.H.M. Rutten, MD, PHD, Bruce H.R. Wolffenbuttel, MD, PHD, Louis W. Niessen, MD
Journal: Diabetes Care
Diabetes Care 2002;25(3):458–463
https://doi.org/10.2337/diacare.25.3.458
Published: 01 March 2002
View articletitled, Health-Related Quality of Life and Treatment Satisfaction in Dutch Patients With Type 2 Diabetes
Open the PDF for Health-Related Quality of Life and Treatment Satisfaction in Dutch Patients With Type 2 Diabetes in another window